This segment focuses on the development, manufacturing, and commercialization of catheter-based thrombectomy devices, primarily for the treatment of venous thromboembolic diseases, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Research and development activities include continuous improvement of existing devices like ClotTriever and FlowTriever, as well as the development of new technologies to address unmet needs in venous disease treatment. Technologies used include mechanical thrombectomy systems, aspiration catheters, and large bore access devices. The therapeutic areas covered are primarily cardiology and vascular surgery. The patient impact is significant, as these devices offer minimally invasive alternatives to traditional treatments, improving patient outcomes and reducing the risk of complications. Inari Medical holds a strong market position due to its innovative products and focus on the venous space. Future opportunities include expansion into new geographic markets and the development of next-generation devices. Regulatory and clinical aspects are crucial, with ongoing clinical trials and registries to support product approvals and reimbursement. Partnerships with medical societies and hospitals are essential for clinical validation and market access.